ADVANCED OR RECURRENT ENDOMETRIAL CANCER

Clinical trials for ADVANCED OR RECURRENT ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED OR RECURRENT ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for ADVANCED OR RECURRENT ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo tested in fight against advanced uterine cancer

Disease control Ongoing

This study is testing the safety of a two-part treatment for people in Spain with advanced or returning endometrial cancer. About 85 patients will first receive an immunotherapy drug with standard chemotherapy, followed by a maintenance phase with the immunotherapy plus a differe…

Matched conditions: ADVANCED OR RECURRENT ENDOMETRIAL CANCER

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ADVANCED OR RECURRENT ENDOMETRIAL CANCER

Get alerted when new ADVANCED OR RECURRENT ENDOMETRIAL CANCER trials appear

New drug combo tested in fight against advanced uterine cancer